Related references
Note: Only part of the references are listed.Cutting edge:: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells
Charles J. Kroger et al.
JOURNAL OF IMMUNOLOGY (2007)
Immunologic control of tumors by in vivo Fcγ receptor-targeted antigen loading in conjunction with double-stranded RNA-mediated immune modulation
A Bot et al.
JOURNAL OF IMMUNOLOGY (2006)
Multiple costimulatory modalities enhance CTL avidity
JW Hodge et al.
JOURNAL OF IMMUNOLOGY (2005)
Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
SW Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Selective induction of high avidity CTL by altering the balance of signals from APC
S Oh et al.
JOURNAL OF IMMUNOLOGY (2003)
Cross-priming as a predominant mechanism for inducing CD8+ T cell responses in gene gun DNA immunization
JH Cho et al.
JOURNAL OF IMMUNOLOGY (2001)
Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement:: Correlation with CD8αβ versus CD8αα expression
AG Cawthon et al.
JOURNAL OF IMMUNOLOGY (2001)
Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma
M Bellone et al.
JOURNAL OF IMMUNOLOGY (2000)
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity
JK Sandberg et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
